Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study

STUDY OBJECTIVES: To evaluate the efficacy and safety of oral JZP-110, a second-generation wake-promoting agent with dopaminergic and noradrenergic activity, for treatment of impaired wakefulness and excessive sleepiness in adults with narcolepsy. METHODS: This was a phase 2b, randomized, double-bli...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sleep
Egile Nagusiak: Ruoff, Chad, Swick, Todd J., Doekel, Robert, Emsellem, Helene A., Feldman, Neil T., Rosenberg, Russell, Bream, Gary, Khayrallah, Moise A., Lu, Yuan, Black, Jed
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Associated Professional Sleep Societies, LLC 2016
Gaiak:
Neurological Disorders
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4909620/
https://ncbi.nlm.nih.gov/pubmed/27166238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5665/sleep.5968
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak